Sonoma Pharmaceuticals, Inc. (SNOA): Price and Financial Metrics

SNOA POWR Grades

• Value is the dimension where SNOA ranks best; there it ranks ahead of 67.91% of US stocks.
• The strongest trend for SNOA is in Growth, which has been heading down over the past 119 days.
• SNOA ranks lowest in Momentum; there it ranks in the 9th percentile.

SNOA Stock Summary

• SNOA has a higher market value than only 0.87% of US stocks; more precisely, its current market capitalization is $10,408,185.
• Revenue growth over the past 12 months for Sonoma Pharmaceuticals Inc comes in at -40.68%, a number that bests only 4.18% of the US stocks we're tracking.
• Sonoma Pharmaceuticals Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -69.67%, greater than the shareholder yield of only 6.02% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Sonoma Pharmaceuticals Inc are TORM, VRME, NAOV, AOUT, and UTMD.
• SNOA's SEC filings can be seen here. And to visit Sonoma Pharmaceuticals Inc's official web site, go to www.sonomapharma.com.

SNOA Valuation Summary

• In comparison to the median Healthcare stock, SNOA's price/sales ratio is 78.95% lower, now standing at 0.8.
• SNOA's price/sales ratio has moved down 20.2 over the prior 177 months.
• Over the past 177 months, SNOA's EV/EBIT ratio has gone up 2.

Below are key valuation metrics over time for SNOA.

SNOA Growth Metrics

Its 5 year price growth rate is now at -84.27%.
• Its year over year revenue growth rate is now at -1.62%.
• The 2 year cash and equivalents growth rate now stands at -63.33%.

SNOA's revenue has moved down $2,597,000 over the prior 70 months.

The table below shows SNOA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	12.487	-4.329	-5.802
2021-09-30	14.521	-3.257	-5.508
2021-06-30	16.546	-2.31	-5.288
2021-03-31	18.629	-3.378	-3.95
2020-12-31	21.051	-5.493	-1.664
2020-09-30	20.793	-7.079	-2.098

SNOA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SNOA has a Quality Grade of D, ranking ahead of 19.4% of graded US stocks.
• SNOA's asset turnover comes in at 1.011 -- ranking 24th of 682 Pharmaceutical Products stocks.
• AGLE, REGN, and NAVB are the stocks whose asset turnover ratios are most correlated with SNOA.

The table below shows SNOA's key quality metrics over time.